INFECTION AND IMMUNITY

Edit Your Profile

INFECTION AND IMMUNITY Journal

publication venue for

Exoenzyme S ADP-ribosylates Rab5 effector sites to uncouple intracellular trafficking.. 82:21-28. 2014
Regulation of Rab5 Function during Phagocytosis of Live Pseudomonas aeruginosa in Macrophages. 81:2426-2436. 2013
Identification of Cytokeratin 18 as a Biomarker of Mouse and Human Hepatosplenic Schistosomiasis. 79:2051-2058. 2011
Differential Patterns of Liver Proteins in Experimental Murine Hepatosplenic Schistosomiasis. 78:618-628. 2010
Discriminating Virulence Mechanisms among Bacillus anthracis Strains by Using a Murine Subcutaneous Infection Model. 77:429-435. 2009
Cerebrospinal fluid-infiltrating CD4+ T cells recognize Borrelia burgdorferi lysine-enriched protein domains and central nervous system autoantigens in early lyme encephalitis. 75:243-251. 2007
Differential binding of host complement inhibitor factor H by Borrelia burgdorferi Erp surface proteins: A possible mechanism underlying the expansive host range of Lyme disease spirochetes. 70:491-497. 2002
ADP-ribosylation of Rab5 by ExoS of Pseudomonas aeruginosa affects endocytosis. 69:5329-5334. 2001
Borrelia burgdorferi RevA antigen is a surface-exposed outer membrane protein whose expression is regulated in response to environmental temperature and pH. 69:5286-5293. 2001
Distinct regulatory pathways control expression of Borrelia burgdorferi infection-associated OspC and Erp surface proteins. 69:4146-4153. 2001
Lipopolysaccharide complexes with Pasteurella haemolytica leukotoxin. 67:2920-2927. 1999
Stability of erp loci during Borrelia burgdorferi infection: Recombination is not required for chronic infection of immunocompetent mice. 67:3146-3150. 1999
Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopes. 65:3430-3437. 1997
Identification of a nonameric H-2K(k)-restricted CD8+ cytotoxic T lymphocyte epitope on the Plasmodium falciparum circumsporozoite protein. 63:1955-1959. 1995
A chemically synthesized peptide which elicits humoral and cellular immune responses to mycobacterial antigens. 53:560-564. 1986
A completely synthetic toxoid vaccine containing Escherichia coli heat-stable toxin and antigenic determinants of the heat-labile toxin B subunit. 48:735-740. 1985
Mucosal antitoxin response in volunteers to immunization with a synthetic peptide of Escherichia coli heat-stable enterotoxin. 50:328-332. 1985
Differences in cross-protection in rats immunized with the B subunits of cholera toxin and Escherichia coli heat-labile toxin. 43:811-816. 1984
Properties of cross-linked toxoid vaccines made with hyperantigenic forms of synthetic Escherichia coli heat-stable toxin. 44:268-273. 1984
Immunological properties of purified Klebsiella pneumoniae heat-stable enterotoxin. 42:838-841. 1983
Properties of synthetically produced Escherichia coli heat-stable enterotoxin. 39:117-121. 1983
Protection against human and porcine enterotoxigenic strains of Escherichia coli in rats immunized with a cross-linked toxoid vaccine. 40:924-929. 1983
Protection in rabbits immunized with a vaccine of Escherichia coli heat-stable toxin cross-linked to the heat-labile toxin B subunit. 40:888-893. 1983
MODIFIED HEMOLYTIC PLAQUE TECHNIQUE FOR DETECTION OF BLUETONGUE VIRUS ANTIBODY-FORMING-CELLS. 13:1321-1324. 1976
Calcium requirement and magnesium stimulation of Escherichia coli L-form induction.. 6:880-882. 1972

category

IMMUNOLOGY Category
INFECTIOUS DISEASES Category

International Standard Serial Number (ISSN)

0019-9567

journal abbreviation

INFECT IMMUN